Myeloid Malignancy Variant Curation Expert Panel

This Expert Panel co-supported by ASH will curate variants in genes associated with inherited risk for myeloid malignancies. This panel will consider variants in genes that cause life-long thrombocytopenia (e.g., RUNX1, ANKRD26, and ETV6) as well as those associated only with cancer risk (e.g., DDX41 and CEBPA).

Expert Status - In progress

Step 1
Step 2
Step 3
Step 4
Define Group
In progress
Develop Classification Rules
Pilot Rules
Expert Panel Approval


Lucy A. Godley, M.D., Ph.D.

David Wu, M.D., Ph.D.


Please contact a coordinator if you have questions.

Xi Luo, PhD


Membership in this committee spans many fields, including genetics, medical, academia, and industry. [View Members]
For more information, please contact:

Xi Luo, PhD


A systematic process of evaluating evidence to classify a genomic variant on a spectrum from pathogenic to benign with respect to a particular disease and inheritance pattern.